Reference number : GC-2017-Q4-01905, amendment number : , agreement type : G, recipient legal name : Willerth, Stephanie (University of Victoria), recipient country : CA, recipient province : nan, recipient city : British Columbia|Colombie-Britannique, recipient postal code : nan, program name english : Engage Grants for universities, program name french : Subventions d'engagement partenarial pour les universités, program purpose english : This project will initiate a first time collaboration between the Willerth laboratory at the University of Victoria_x000D_
and Immunoprecise Antibodies Ltd. located in Victoria, B.C. Immunoprecise Antibodies Ltd. is a local_x000D_
biotechnology company with over 25 years of experience in the custom antibody business. One of their major_x000D_
products includes their proprietary technology for generating custom rabbit monoclonal antibodies using their_x000D_
technology, which screens the immune repertoire of the rabbit for selecting the desired antibody directly from_x000D_
B cells. The major goal of this Engage project is to develop a work flow for analyzing the antibody populations_x000D_
produced in these rabbit systems using next generation sequencing as a way to streamline the antibody_x000D_
production process. The major challenges will be 1) obtaining sequencing data from the population of immune_x000D_
cells and 2) analyzing the resulting sequence data using bioinformatics. The Willerth lab will provide personnel_x000D_
and expertise to achieve these goals. This project will train highly qualified personnel in the areas of_x000D_
biotechnology, cell culture, and bioinformatics., program purpose french : This project will initiate a first time collaboration between the Willerth laboratory at the University of Victoria_x000D_
and Immunoprecise Antibodies Ltd. located in Victoria, B.C. Immunoprecise Antibodies Ltd. is a local_x000D_
biotechnology company with over 25 years of experience in the custom antibody business. One of their major_x000D_
products includes their proprietary technology for generating custom rabbit monoclonal antibodies using their_x000D_
technology, which screens the immune repertoire of the rabbit for selecting the desired antibody directly from_x000D_
B cells. The major goal of this Engage project is to develop a work flow for analyzing the antibody populations_x000D_
produced in these rabbit systems using next generation sequencing as a way to streamline the antibody_x000D_
production process. The major challenges will be 1) obtaining sequencing data from the population of immune_x000D_
cells and 2) analyzing the resulting sequence data using bioinformatics. The Willerth lab will provide personnel_x000D_
and expertise to achieve these goals. This project will train highly qualified personnel in the areas of_x000D_
biotechnology, cell culture, and bioinformatics., agreement title english : Developing an Ig-Seq workflow for analyzing populations of rabbit monoclonal antibodies, agreement title french : Developing an Ig-Seq workflow for analyzing populations of rabbit monoclonal antibodies, agreement number : EGP, agreement value : 25000.0, agreement start date : 2018-03-07, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2018-2019)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada